This article may be reprinted free of charge provided 1) that there is clear attribution to the Orthomolecular Medicine News Service, and 2) that both the OMNS free subscription link http://orthomolecular.org/subscribe.html and also the OMNS archive link http://orthomolecular.org/resources/omns/index.shtml are included.
FOR IMMEDIATE RELEASE
Orthomolecular Medicine News Service, July 2, 2019
WHY VITAMIN C FIGHTS CANCER SO WELL
And why more and more oncologists are now using it
Commentary by Andrew W. Saul, Editor
(OMNS July 2, 2019) The success of intravenous vitamin C for cancer patients is a repeatedly-demonstrated clinical reality. Here is the full, detailed Riordan IVC protocol, a free download for everyone.
Do not let loved ones suffer unnecessarily from one-sided care directed exclusively by physicians educated in pharmaceutical-funded medical schools. Bring your oncologist up to speed. No more leeches; no more calomel. No more procrastination about utilizing nutritional therapy. Enough is enough! Drop this protocol on your doctor's desk and demand an IV of vitamin C now. If the doctor refuses, go over their head or sue them for denying treatment.
Cancer cells are killed by vitamin C precisely because cancer cells are different. Inside a cancer cell, vitamin C, normally an antioxidant in a healthy cell, actually acts as a pro-oxidant and kills a cancer cell. Give enough C and you can kill malignant cells almost anywhere they may try to spread or try to hide.
Because pancreatic cancer is notoriously difficult to stop, administering vitamin C is all the more important. Here is a free download for a paper showing clinical success with very high-dose IV vitamin C against stage 4 pancreatic cancer.
The senior author, Jeanne A. Drisko, MD, is a diagnostic radiology specialist and professor at the University of Kansas, Division of Integrative Medicine.
Ovarian cancer was successfully treated in two patients with very high dose vitamin C therapy. Free download of the paper at
Since ovarian cancer is particularly dangerous, this finding needs to be shared far and wide. The study was done in 2003 and still a whole lot of people have not heard about it. Once again, it's the research of Jeanne Drisko, MD, and colleagues.
Vitamin C does not "interfere" with chemo
Antioxidants and other nutrients do not interfere with chemotherapy or radiation therapy and can increase survival. (Simone CB 2nd, Simone NL, Simone V, Simone CB. Altern Ther Health Med. 2007;13:22-28.
See also: Block K, Koch AC, Mead MN, Tothy PK, Newman RA, Gyllenhaal C. Impact of antioxidant supplementation on chemotherapeutic toxicity: a systematic review of the evidence from randomized controlled trials. Int J Cancer. 2008;123:1227-1239. doi: 10.1002/ijc.23754.
"At high concentrations, ascorbate does not interfere with chemotherapy or irradiation and may enhance efficacy in some situations . . . Meta-analyses of clinical studies involving cancer and vitamins also conclude that antioxidant supplementation does not interfere with the efficacy of chemotherapy."
( https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751545 )
No, vitamin C does not "interfere" with chemo. I'm going to hit at this again and again. Why? Because innocent patients are suffering needlessly, and that really ticks me off. One of the original urban legends about chemo interference was hatched by Sloan-Kettering back in 2008. Here's the real story.
Not only does vitamin C not interfere with chemo, the vitamin itself IS chemotherapy against cancer. Vitamin C given intravenously is selectively toxic to cancer cells.
And while various oral forms are very helpful adjuncts, when fighting cancer, it has to be intravenous C to get the job done right.
Why a cancer patient receiving conventional treatment also needs vitamin C:
- Vitamin C reduces the side effects of chemo.
- Vitamin C reduces the side effects of radiation.
- Vitamin C reduces post-surgical inflammation and infection, and reduces healing time.
Cancer patients can and should take antioxidants and other nutritional supplements while undergoing radiation therapy or chemotherapy. Vitamin C and other nutrients reduce side effects, and actually improve the results with both chemo and radiation.
Radiation oncologist Victor Marcial-Vega, MD always administers high dose vitamin C therapy to his cancer patients. He says, "Vitamin C has two effects. It increases the beneficial effects of radiation and chemotherapy and decreases the adverse effects. Once you start using IV vitamin C, the effect is so dramatic that it is difficult to go back to not using it."
"Vitamin C increases the beneficial effects of radiation and chemotherapy and decreases the adverse effects. But this is not a subtle effect, is not 15-20%, it's a dramatic effect. Once you start using IV vitamin C, the effect is so dramatic that it is difficult to go back to not using it."
( Victor Marcial-Vega, MD En espanol: https://www.youtube.com/watch?v=JbOXgG998fI )
Chemotherapy for cancer actually is effective . . . in just over 2% of the cases. (Morgan G, Ward R, Barton M. The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies. Clin Oncol (R Coll Radiol). 2004 Dec;16(8):549-60.
Radiation on localized tumors fares far better. Either way, nutritional support reduces side effects of such harsh treatments. Face facts: you are going to get nowhere with an oncologist if you flatly reject what they have to offer. And most patients and their families, scared out of their wits by a cancer diagnosis, are going to listen to that oncologist and use conventional therapy. If you want the doctors to listen to you, be ready to compromise with them. Then have something to say and give them an earful. This may help:
"After breakfast, I visited Linus Pauling who was staying in the room next to mine. When I walked in he was busy with a hand calculator. I told him that on the basis of my fifty patients I had concluded that he and Dr. Cameron were right, that vitamin C in large doses did improve enormously the outcome of treatment for cancer."
( Orthomolecular Treatment of Cancer, by Abram Hoffer, MD, PhD
Physicians have been successfully using vitamin C against cancer since the 1970s and 80s. Those telling you otherwise are misinformed. Twenty-two years ago it was confirmed and reconfirmed that high-dose IV vitamin C is effective against cancer.
How long do patients have to wait for it to be accepted as an essential, standard therapy? In Japan, it already is, says NEWSWEEK:
For those wanting to know precisely how vitamin C fights cancer, here you go:
Ron Hunninghake, MD, is the presenter. The second half is more directly about intravenous vitamin C. Dr. Hunninghake is medical director of the Riordan Clinic. He has decades of experience and has supervised tens of thousands of IV vitamin C treatments. As your own life progresses, observe how many critics of vitamin C are so certain of their negative beliefs that they will never view this video.
Vitamin IVs can be arranged in virtually any hospital, anywhere in the world . . . if you push hard enough. Learn how from an attorney - who also just happens to be a board-certified cardiologist. Free download of a presentation by Thomas E. Levy, MD, JD.
A final note concerning intravenous vitamin C: Do not accept stories that "the hospital can't" or "the doctor can't" or that "the state won't allow it." If you hear any of this malarkey, send me the text of the policy or the law that says so. In the meantime, here is how to take the reins and get the vitamin in the veins:
Copyright 2019 by Andrew W. Saul. Reprinted by the Orthomolecular Medicine News Service with the permission of the author.
Nutritional Medicine is Orthomolecular Medicine
Orthomolecular medicine uses safe, effective nutritional therapy to fight illness. For more information: http://www.orthomolecular.org
Find a Doctor
To locate an orthomolecular physician near you: http://orthomolecular.org/resources/omns/v06n09.shtml
The peer-reviewed Orthomolecular Medicine News Service is a non-profit and non-commercial informational resource.
Editorial Review Board:
Ilyès Baghli, M.D. (Algeria)
Ian Brighthope, M.D. (Australia)
Prof. Gilbert Henri Crussol (Spain)
Carolyn Dean, M.D., N.D. (USA)
Damien Downing, M.D. (United Kingdom)
Michael Ellis, M.D. (Australia)
Martin P. Gallagher, M.D., D.C. (USA)
Michael J. Gonzalez, N.M.D., D.Sc., Ph.D. (Puerto Rico)
William B. Grant, Ph.D. (USA)
Tonya S. Heyman, M.D. (USA)
Suzanne Humphries, M.D. (USA)
Ron Hunninghake, M.D. (USA)
Michael Janson, M.D. (USA)
Robert E. Jenkins, D.C. (USA)
Bo H. Jonsson, M.D., Ph.D. (Sweden)
Jeffrey J. Kotulski, D.O. (USA)
Peter H. Lauda, M.D. (Austria)
Thomas Levy, M.D., J.D. (USA)
Homer Lim, M.D. (Philippines)
Stuart Lindsey, Pharm.D. (USA)
Victor A. Marcial-Vega, M.D. (Puerto Rico)
Charles C. Mary, Jr., M.D. (USA)
Mignonne Mary, M.D. (USA)
Jun Matsuyama, M.D., Ph.D. (Japan)
Dave McCarthy, M.D. (USA)
Joseph Mercola, D.O. (USA)
Jorge R. Miranda-Massari, Pharm.D. (Puerto Rico)
Karin Munsterhjelm-Ahumada, M.D. (Finland)
Tahar Naili, M.D. (Algeria)
W. Todd Penberthy, Ph.D. (USA)
Dag Viljen Poleszynski, Ph.D. (Norway)
Jeffrey A. Ruterbusch, D.O. (USA)
Gert E. Schuitemaker, Ph.D. (Netherlands)
Thomas L. Taxman, M.D. (USA)
Jagan Nathan Vamanan, M.D. (India)
Garry Vickar, MD (USA)
Ken Walker, M.D. (Canada)
Anne Zauderer, D.C. (USA)
Andrew W. Saul, Ph.D. (USA), Editor-In-Chief
Editor, Japanese Edition: Atsuo Yanagisawa, M.D., Ph.D. (Japan)
Robert G. Smith, Ph.D. (USA), Associate Editor
Helen Saul Case, M.S. (USA), Assistant Editor
Ralph K. Campbell, M.D. (USA), Contributing Editor
Michael S. Stewart, B.Sc.C.S. (USA), Technology Editor
Jason M. Saul, JD (USA), Legal Consultant
Comments and media contact: email@example.com OMNS welcomes but is unable to respond to individual reader emails. Reader comments become the property of OMNS and may or may not be used for publication.
To Subscribe at no charge: http://www.orthomolecular.org/subscribe.html
To Unsubscribe from this list: http://www.orthomolecular.org/unsubscribe.html